No Data
Special Treat Xiangxue (300147.SZ): The Guangzhou Intermediate Court has approved the company's pre-reorganization and appointed a temporary administrator.
Special Treat Xiangxue (300147.SZ) issued an announcement that on April 11, 2025, the company received a notice from the Guangzhou Intermediate People's Court...
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
The market continues to shrink and adjust, raising concerns about a retreat in the Siasun Robot&Automation Sector. Can the deep-sea Technology Concept hold the flag and launch a counterattack?
Track the entire lifecycle of the main Sector.
Express News | Xiangxue Pharmaceutical Says Receives Advance Notice of Administrative Punishment From Chinese Securities Regulator
Xiangxue Pharmaceutical (300147.SZ) is subject to Other risk warning and will be suspended for 1 day on March 24.
Xiangxue Pharmaceutical (300147.SZ) announced that on March 21, 2025, the company received a notice from the China Securities Regulatory Commission...
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) 29% Dip In Price Shows Sentiment Is Matching Revenues
